Vitrolife AB

VTFN

Company Profile

  • Business description

    Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The company has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.

  • Contact

    Box 9080
    Gothenburg400 92
    SWE

    T: +46 317218000

    https://www.vitrolife.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    1,103

Stocks News & Analysis

stocks

Fair value upgrade for ASX listed fast food chain

Earnings beat lifts forecasts but long term growth questions remain.
stocks

Going into earnings, is Nvidia stock a buy, a sell, or fairly valued?

We’re expecting another beat-and-raise quarter, while watching the roadmap and discussions of its financing and partnership deals.
stocks

Wide moat airport share steps up its investments

Profits flatten as airport ramps up redevelopment.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,370.1045.600.49%
CAC 408,453.0131.42-0.37%
DAX 4026,106.6029.96-0.11%
Dow JONES (US)53,417.16140.150.26%
FTSE 10010,854.3237.760.35%
HKSE25,427.5989.74-0.35%
NASDAQ25,980.19200.27-0.76%
Nikkei 22565,785.09257.000.39%
NZX 50 Index14,000.99119.110.86%
S&P 5007,652.8621.51-0.28%
S&P/ASX 2009,162.5052.200.57%
SSE Composite Index3,876.385.63-0.14%

Market Movers